Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study)

Laura R Loehr1, Wayne D Rosamond, Patricia P Chang

  • 1University of North Carolina at Chapel Hill, NC, USA. lloehr@email.unc.edu <lloehr@email.unc.edu>

Insights

Heart failure (HF) incidence is higher in African-Americans and men than Caucasian women. Early in follow-up, women had higher HF risk, but this trend reversed later, with greater HF case fatality in African-Americans.

Area of Science:

  • Cardiovascular epidemiology
  • Public health research
  • Clinical investigation

Background:

  • Heart failure (HF) prevalence is rising in the U.S.
  • Limited data exists on racial and gender disparities in HF incidence and case fatality.

Purpose of the Study:

  • To investigate differences in heart failure incidence and case fatality rates based on race and gender.
  • To analyze trends in HF risk over time within different demographic groups.

Main Methods:

  • Utilized the Atherosclerosis Risk in Communities (ARIC) cohort study (1987-2002).
  • Defined incident HF using International Classification of Diseases codes from hospitalizations or death certificates.
  • Analyzed 1,282 incident HF cases over 198,417 person-years, adjusting for confounders.

Main Results:

  • Age-adjusted HF incidence rates were highest in African-American men (9.1/1000 person-years) and lowest in Caucasian women (3.4/1000 person-years).
  • African-American women exhibited HF incidence rates similar to men.
  • African-Americans showed higher 5-year case fatality compared to Caucasians.
  • Women experienced a higher hazard ratio for HF during the initial follow-up period.

Conclusions:

  • Heart failure incidence in African-American women mirrors that of men, differing significantly from Caucasian women.
  • Disparities in HF incidence between African-Americans and Caucasians are largely attributable to differences in atherosclerotic risk factors.
  • Addressing risk factors is crucial for mitigating HF disparities.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...